Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Epocrates Bugs + Drugs App Goes Viral With 100,000 Downloads in First Month



Epocrates Bugs + Drugs App Goes Viral With 100,000 Downloads in First Month

New App Improves Clinician Awareness of Local "Superbugs" and Informs Rx
Decisions

WATERTOWN, Mass., Oct. 31, 2013 (GLOBE NEWSWIRE) -- athenahealth, Inc.
(Nasdaq:ATHN) and Epocrates today announced that the new joint medical app,
Epocrates Bugs + Drugs, has hit the 100,000 download mark since its release
earlier this month. Epocrates Bugs + Drugs, an antimicrobial susceptibility
reference sourced from athenahealth's big data that helps clinicians identify
local superbugs, shot to the #1 free medical app in Apple's App Store in its
first week. To date, it has earned 4+ stars, with users calling it "sleek and
informative," "super fast" and a "pretty awesome concept."

The majority of targeted bacterial searches in the app are in higher-risk
metropolitan areas, such as New York, Los Angeles, and Chicago. Furthermore,
the localized sensitivity patterns for organisms including E. coli and Staph
aureus, commonly found in urine and skin infections, are among the most viewed
by the app's users.

Dr. Gerry Tolbert, a family physician, was initially drawn to the beautiful
design of the Epocrates Bugs + Drugs app. The app's value was quickly evident
during patient consultations, and it has since earned a spot in his practice
toolkit. "It is sometimes challenging to judge what the resistance is for a
presenting bacteria. By displaying resistance patterns in my area, Epocrates
Bugs + Drugs helps ensure that I prescribe only one course of antibiotic and
avoid medications that have shown to be resistant," said Dr. Tolbert.
"Epocrates helps me create a successful treatment plan, which provides higher
levels of patient compliance and satisfaction."

"We add more than 6,000 lab isolate data points every day to the network to
generate fresh results. This is a great example of how aggregated EHR data can
be utilized, and clinicians have clearly responded to it. The app has now been
accessed more than 300,000 times since launch, with an average of
approximately 4,000 uses a day," said Abbe Don, vice president of user
experience at Epocrates, an athenahealth company.

Epocrates Bugs + Drugs was created to provide the nation's clinicians with
geo-located bacterial resistance data sourced from athenahealth's cloud-based
clinical database of 15 million patient records. Results can be viewed for
bacteria by specimen types and is paired with Epocrates' trusted drug content
to inform prescribing decisions.

Epocrates Bugs + Drugs is now available at no cost for iOS 7 devices in the
Apple App Store: http://bit.ly/18uyL3n.

About Epocrates, Inc.

Epocrates, Inc., an athenahealth company, is recognized for developing the #1
medical application among U.S. physicians for clinical content, practice
tools, and health industry engagement at the point of care. Epocrates has
established a loyal network of more than one million health care
professionals, including 50 percent of U.S. physicians, who routinely use its
intuitive solutions to help streamline workflow and improve patient care. For
more information, please visit www.epocrates.com/company.

About athenahealth, Inc.

athenahealth is a leading provider of cloud-based services for electronic
health record (EHR), practice management, and care coordination.
athenahealth's mission is to be caregivers' most trusted service, helping them
do well doing the right thing. For more information, please visit
www.athenahealth.com.

Apple is a registered trademark and App Store is a registered service mark of
Apple Inc.

CONTACT: Erica Morgenstern
         Epocrates, Inc. (Media)
         pr@epocrates.com
         650-227-6907
        
         Holly Spring
         athenahealth, Inc. (Media)
         hspring@athenahealth.com
         617-402-1631
        
         Dana Quattrochi
         athenahealth, Inc. (Investors)
         investorrelations@athenahealth.com
         617-402-1329

athenahealth, Inc. logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement